Single-Cell Omics Market
According to Intent Market Research, the Single-Cell Omics Market is expected to grow from USD 1.9 Billion in 2024-e at a CAGR of 18.1% to touch USD 5.3 Billion by 2030. The Single-Cell Omics Market is dominated by key players such as Illumina, Inc., Becton, Dickinson and Company (BD Biosciences), Fluidigm Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc.